ArticleJournal of robotic surgery2026
Robotic breast surgery with and without tunneling using the tumescent technique.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The tumescent technique has traditionally been used in nipple-sparing mastectomy to help dissection and reduce bleeding. However, its necessity in robotic nipple-sparing mastectomy (RNSM) remains unclear due to enhanced visualization offered by robotic systems. This study analyzed the feasibility of omitting tumescent in RNSM by comparing postoperative outcomes and operative times. We retrospectively reviewed 253 patients who underwent unilateral RNSM at Asan Medical Center from October 2020 to November 2023. Outcomes included adverse events classified by Clavien-Dindo system and operative times. Indocyanine green (ICG) fluorescence imaging was used to assess ischemia patterns. The tumescent group (n = 43) exhibited a higher incidence of adverse events (16.3% vs. 5.2%, P = 0.025) and hematomas (11.6% vs. 2.4%, P = 0.016) compared to the non-tumescent group (n = 210). The mean operative times for mastectomy was shorter in the tumescent group (129.4 min vs. 165.9 min, p < 0.001); however, the overall surgical time was not significantly different P = 0.827). ICG fluorescence imaging showed higher rates of diffuse pattern ischemia (P = 0.059) and NAC ischemia patterns (P = 0.015) within the tumescent group; however, these patterns were not associated with grade II or higher adverse events. Omitting tumescent in RNSM is feasible and may reduce postoperative complications, particularly hematoma, while maintaining comparable operative time and minimizing unnecessary flap trimming due to false-positive ischemia on ICG fluorescence imaging.
Indexed as
Identifiers
41692925What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.